100 Results for "

ALK5

" in MedChemExpress (MCE) Product Catalog:
Products (100)

100 Results for "ALK5" in MCE Product Catalog:

313
313 Publications Verification
Cat. No.: HY-10431
CAS No.: 301836-41-9
Purity:  99.85%
Research Areas:  

Cancer

SB-431542 is a TGF-β receptor kinase inhibitor (TRKI). SB-431542 has inhibitory activity for ALK4, ALK5 and ALK7 with IC50 values of 1 μM, 0.75 μM and 2 μM, respectively. SB-431542 also inhibits TGF-β-induced transcription, gene expression, apoptosis, and growth suppression. SB-431542 can be used for the research of cancer and signal transduction pathways .
loading...
    loading...
141
141 Cited Publications
Cat. No.: HY-10432
CAS No.: 909910-43-6
Purity:  99.33%
Research Areas:  

Cancer

A 83-01 is a potent inhibitor of TGF-β type I receptor ALK5 kinase, type I nodal receptor ALK4 and type I nodal receptor ALK7, with IC50s of 12 nM, 45 nM and 7.5 nM against the transcription induced by ALK5, ALK4 and ALK7, respectively .
loading...
    loading...
141
141 Cited Publications
Cat. No.: HY-10432A
CAS No.: 2828431-89-4
Purity:  98.43%
Research Areas:  

Cancer

A 83-01 sodium is a potent inhibitor of TGF-β type I receptor ALK5 kinase, ALK4 and ALK7, with IC50s of 12 nM, 45 nM and 7.5 nM against the transcription induced by ALK5, ALK4 and ALK7, respectively .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-13521
CAS No.: 694433-59-5
Purity:  99.73%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

SB-505124 is a selective inhibitor of TGF-β Receptor type I receptors (ALK4, ALK5, ALK7), with IC50s of 129 nM and 47 nM for ALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-13521A
CAS No.: 356559-13-2
Purity:  99.34%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

SB-505124 hydrochloride is a selective inhibitor of TGF-β Receptor type I receptor (ALK4, ALK5, ALK7), with IC50s of 129 nM and 47 nM for ALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-13012
CAS No.: 446859-33-2
Purity:  99.92%
Synonyms: E-616452; SJN 2511
Research Areas:  

Metabolic Disease

RepSox (E-616452) is a potent and selective transforming growth factor-beta receptor I/activin like kinase 5 (TGF-β-RI/ALK5) inhibitor. RepSox inhibits ALK5 autophosphorylation with an IC50 value of 4 nM. RepSox can be used for the research of obesity and associated metabolic diseases such as type 2 diabetes .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-12043
CAS No.: 356559-20-1
Purity:  99.97%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

SB 525334 is a potent and selective transforming growth factor β1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-10326
CAS No.: 452342-67-5
Purity:  99.92%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, and also inhibits TGF-β type II receptor and activin type II receptor activities, without inhibiting BMP type II receptor.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19928
CAS No.: 1352608-82-2
Synonyms: EW-7197; TEW-7197
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Vactosertib (EW-7197) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib has potently antimetastatic activity and anticancer effect .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-103021
CAS No.: 1898283-02-7
Purity:  99.87%
Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology Cancer

LY3200882 is a potent, highly selective, ATP-competitive and orally active TGF-β receptor type 1 (ALK5) inhibitor with an IC50 of 38.2 nM. LY3200882 inhibits various pro-tumorigenic activities and is also used as an immune modulatory agent .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19928A
CAS No.: 1352610-25-3
Synonyms: EW-7197 Hydrochloride; TEW-7197 Hydrochloride
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Vactosertib Hydrochloride (EW-7197 Hydrochloride) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib Hydrochloride also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib Hydrochloride has potently antimetastatic activity and anticancer effect .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-13227
CAS No.: 627536-09-8
Purity:  99.44%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, and > 100-fold selectivity over TGF-βRII.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111482
CAS No.: 614749-78-9
Purity:  99.82%
SM 16 is a ALK5/ALK4 kinase inhibitor with Kis of 10 and 1.5 nM, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16712
CAS No.: 1627503-67-6
Target:  

TGF-β Receptor

Research Areas:  

Cancer

LDN-214117 is an orally active ALK2 inhibitor with well-tolerated and good brain penetration. LDN-214117 has a high selectivity and low cytotoxicity for ALK2 with an IC50 value of 24 nM. LDN-214117 also is a specific bone morphogenetic proteins (BMPs) signaling inhibitor and has relatively selective inhibition for BMP6 with an IC50 value of 100 nM. LDN-214117 can be used for the research of fibrodysplasia ossificans progressiva (FOP), diffuse intrinsic pontine glioma (DIPG) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-18758
CAS No.: 868612-83-3
Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology Cancer

IN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and p38α mitogen-activated protein kinase (IC50=4.3 μM). IN-1130 suppresses renal fibrosis in obstructive nephropathy and blocks breast cancer lung metastasis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-78349
CAS No.: 607737-87-1
Target:  

TGF-β Receptor

Research Areas:  

Cancer

A 77-01 is a potent inhibitor of transforming growth factor (TGF)-β type I receptor superfamily activin-like kinase ALK5 with an IC50 of 25 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-118528A
CAS No.: 2459963-17-6
Purity:  99.22%
Target:  

TGF-β Receptor

Research Areas:  

Endocrinology

TP0427736 hydrochloride is a potent inhibitor of ALK5 kinase activity with an IC50 of 2.72 nM and this effect is 300-fold higher than the inhibitory effect on ALK3 (IC50=836 nM). TP0427736 hydrochloride also inhibits Smad2/3 phosphorylation in A549 cells induced by TGF-β1 with an IC50 value of 8.68 nM. TP0427736 hydrochloride can be used for the research of androgenic alopecia (AGA) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P72454
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGF-beta receptor type-1; ALK-5; SKR4; TbetaR-I; AAT5
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18766
CAS No.: 1352609-28-9
Research Areas:  

Cancer

EW-7195 is a potent and selective ALK5 (TGFβR1) inhibitor with an IC50 of 4.83 nM. EW-7195 has >300-fold selectivity for ALK5 over p38α. EW-7195 efficiently inhibits TGF-β1-induced Smad signaling, epithelial-to-mesenchymal transition (EMT) and breast tumour metastasis to the lung .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N4107
CAS No.: 10351-88-9
Phyllanthin is an effective oral anticancer agent. Phyllanthin inhibits MOLT-4 cell viability, increases apoptosis, inhibits cell migration and invasion. Phyllanthin exerts anti-fibrotic effects by down-regulating TGF signaling pathway via ALK5 and Smad2/3. Phyllanthin also has anti-inflammatory and antibacterial properties .
loading...
    loading...